Matches in Nanopublications for { ?s ?p "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP372503.RAYAmHGl3dIXxsXCPEt7dDRFTHT7R7cbVRFaqv8-WkAmQ130_assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372503.RAYAmHGl3dIXxsXCPEt7dDRFTHT7R7cbVRFaqv8-WkAmQ130_provenance.
- NP857797.RAWhLU8cIK3wyvMu_TlZuF94E3e5NNmMwH9jMKodmaYFg130_assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857797.RAWhLU8cIK3wyvMu_TlZuF94E3e5NNmMwH9jMKodmaYFg130_provenance.
- NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_provenance.
- NP767910.RAZGt0LqYcVJ3bUR1E8C7gFqIHwFoAUbQdRE15uaXeFqg130_assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767910.RAZGt0LqYcVJ3bUR1E8C7gFqIHwFoAUbQdRE15uaXeFqg130_provenance.
- NP767914.RAT_bAJhPMRQJ5KYIcWr89aOTJIDCmU-KQ_pV9rKyqFks130_assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767914.RAT_bAJhPMRQJ5KYIcWr89aOTJIDCmU-KQ_pV9rKyqFks130_provenance.
- NP767906.RAo6Salb7FCmUlRzW1dQvTb7TNmwLAYzYK1QKum2-Apzs130_assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767906.RAo6Salb7FCmUlRzW1dQvTb7TNmwLAYzYK1QKum2-Apzs130_provenance.
- NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_provenance.
- NP698035.RAHWVjwMSDkTHa5bD8OU1UbTwBXyWyhOnJz7ZnsVxK8mQ130_assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698035.RAHWVjwMSDkTHa5bD8OU1UbTwBXyWyhOnJz7ZnsVxK8mQ130_provenance.
- NP767911.RA1treCKBdoAyaRpHe0GS-AmkYJMcbe0W4ZTnP75FSJEo130_assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767911.RA1treCKBdoAyaRpHe0GS-AmkYJMcbe0W4ZTnP75FSJEo130_provenance.
- NP767915.RA8E0oM9RdHXGPqlpyx5duiSFTqh1lSHYrg8GbYHEvmpo130_assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767915.RA8E0oM9RdHXGPqlpyx5duiSFTqh1lSHYrg8GbYHEvmpo130_provenance.